Globe Newswire
Downing LLP LEI: 213800G3X76VBG9SB504 20 May 2024
Form 8.3 re. Lok’n Store Group Plc
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Downing LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): Client funds managed by... (continue reading...)Downing LLP LEI: 213800G3X76VBG9SB504 20 May 2024
Form 8.3 re. Equals Group Plc
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Rule 8.3 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Full name of discloser: Downing LLP (b) Owner or controller of interests and short positions disclosed, if different from 1(a): Client funds managed by Downing... (continue reading...)PHOENIX, May 20, 2024 (GLOBE NEWSWIRE) -- Mesa Air Group, Inc. (NASDAQ: MESA) (“Mesa” or the “Company”) today reported first quarter fiscal 2024 financial and operating results.
First Quarter Fiscal 2024 Update:
- Total operating revenues of $118.8 million
- Pre-tax loss of $57.0 million, net loss of $57.9 million or $(1.41) per diluted share
- Adjusted net loss1 of $21.8 million2 or $(0.53) per diluted share
- Adjusted EBITDAR1 of $6.3 million
- Block hours of 46,658,... (continue reading...)
PETAH TIKVA, Israel, May 20, 2024 (GLOBE NEWSWIRE) -- Gilat Satellite Networks Ltd. (Nasdaq: GILT, TASE: GILT), a worldwide leader in satellite networking technology, solutions, and services, announced today that Nicole Robinson has been appointed as President of DataPath.
Ms. Robinson is an international satellite industry executive with a proven record in driving growth, managing global sales and operational teams, and deploying next-generation technology for... (continue reading...)
-- Researchers to Present New Phase 2 Data Showing Safety and Anti-Leukemic Activity with WU-CART-007 and Additional New Findings for this Investigational, Off-the-Shelf Allogeneic CAR-T Cell Therapy
-- Company to Initiate Follow-Up Study in Q4 2024 with WU-CART-007 in Pediatric and Minimal Residual Disease (MRD) Patients
-- Will Share New Data for WU-NK-101, its Investigational Memory Natural Killer Cell Therapy, at EHA
ST. LOUIS and SAN DIEGO, May 20, 2024 ... (continue reading...)
More Globe Newswire
View Older Stories-
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
-
Ocugen Announces CSO to Present on Modifier Gene Therapy at International Society for Cell & Gene Therapy 2024
-
Aveanna to Participate at the UBS Healthcare Services Cape Cod Summit and Jefferies Global Healthcare Conference
-
Perspective Therapeutics to Present at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Annual Meeting 2024
-
TFF Pharmaceuticals and Cleveland Clinic to Advance Multivalent Universal Influenza Vaccine Candidates into Preclinical Testing
-
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
-
Sol-Gel Reports First Quarter 2024 Financial Results and Provides Corporate Updates
-
Entero Therapeutics Presents Two Posters on Celiac Disease Research at the 2024 Digestive Disease Week (DDW) Conference
-
Novel Medical Food Solution for the Elderly: Pluri & Wilk Collaborate to Develop Human Breast Milk-Derived Food Production on a Commercial Scale
-
Sono-Tek Announces Year-End FY 2024 Earnings Conference Call
-
Highest Performances Holdings Inc. (NASDAQ: HPH) to Announce Unaudited Financial Results For The First Half of The Fiscal Year 2024 and Host Conference Call on May 30, 2024
-
Arqit Quantum Inc. Announces Financial and Operational Results for the First Half of Fiscal Year 2024
-
New Campaign from The Trial for #ClinicalEquality – “Worth Less” –Spotlights the Cost of Clinical Inequality
-
Global-e Reports First Quarter 2024 Results
-
Enlight Announces Participation at Upcoming JP Morgan and Roth MKM Investor Conferences
-
Children International Hosts Ecuadorian Students in Kansas City for Global Finals of ‘Destination Imagination’ Tournament
-
Vivid Seats to Participate in William Blair’s 2024 Growth Stock Conference
-
ECARX Announces First Quarter 2024 Unaudited Financial Results
-
Ageas and Taiping deepen cooperation in pension solutions
-
At278 Ultra-Concentrated Ultra-Rapid Acting Insulin Demonstrates Superiority in Phase i Clinical Trial in Overweight and Obese People With Type 2 Diabetes
-
MAOCAT Presale Is Off to a Successful Start, Raising $300K Already
-
Aesthetic Medical International Holdings Group Ltd. Announces Receipt of Delisting Decision from the Nasdaq Hearings Panel
-
ANI Pharmaceuticals Announces the Launch of Kionex® Suspension
-
Bayport Management Ltd announces standstill agreement and is in constructive negotiations with creditors to address its capital structure, cash interest obligations and debt maturities
-
Public Entities of America, LLC joins Apex Insurance Agency, LLC, part of Bridge Specialty Group, LLC
-
Shah Capital Withdraws Proxy Campaign Against Re-Election of Directors at Novavax’s 2024 Annual Meeting
-
Scorpio Tankers Inc. Announces Agreement for a $223.6 Million Prepayment under its 2023 $1.0 Billion Credit Facility
-
Dyne Therapeutics Announces New Clinical Data from ACHIEVE Trial of DYNE-101 in DM1 and DELIVER Trial of DYNE-251 in DMD Demonstrating Compelling Impact on Key Disease Biomarkers and Improvement in Mu
-
Bionomics to Present at the 2024 American Society of Clinical Psychopharmacology Annual Meeting
-
Voyageur Mineral Explorers Corp. Options Alberts Lake Project
-
The Board of Directors of Eezy Plc has resolved to change the target levels of the performance criteria for the fourth performance period of the share-based incentive plan for the company's key employ
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Wood Group (John) plc
-
Brunswick Corporation releases 2023 Corporate Sustainability Report
-
Resolutions of the Annual General Meeting of Shareholders of Aktsiselts Infortar
-
Man Group PLC : Form 8.3 - Redrow plc
-
Man Group PLC : Form 8.3 - Barratt Developments plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - TYMAN PLC - Ordinary Shares
-
Man Group PLC : Form 8.3 - Tyman plc
-
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
-
WOO X Lists $NUTS on its Spot Market
-
PAYCOM ALERT: Bragar Eagel & Squire, P.C. is Investigating Paycom Software, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
-
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
-
Fractyl Health Presents Compelling Preclinical Data from Single-Administration GLP-1 Pancreatic Gene Therapy Rejuva® at Digestive Disease Week 2024
-
Bempedoic Acid Met Primary Endpoint of Phase 3 Trial in Japan for the Treatment for Hypercholesterolemia
-
Dimensional Fund Advisors Ltd. : Form 8.3 - INTERNATIONAL PAPER CO - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - BARRATT DEVELOPMENTS PLC - Ordinary Shares
-
Invesco Ltd: Form 8.3 - Anglo American PLC
-
Form 8.3 - International Distributions Services Plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DS SMITH PLC - Ordinary Shares
-
Ferrari N.V.: Periodic Report on the Buyback Program